With research activities gradually resuming, research teams may be challenged with conducting their trials effectively and efficiently. Here’s how Staff Augmentation can help.
The site-sponsor relationship is a multi-faceted one. The need for communication and understanding between the two is prevalent now more than ever.
The global pandemic has changed the way we think about research. Sponsors should consider how the “new normal” will impact sites and current studies as they plan to re-start research.
Learn how to find the right individual to manage your clinical research projects and improve the efficiency of your clinical trials.
While the clinical research community is currently being challenged by the COVID-19 pandemic, adaptive and platform study designs may provide much-needed help for sites.
Strategies for convincing leadership to invest in the tools needed to optimize operations and inform strategic decision-making.
Recent regulations and policies have ushered in the era of mandated single IRB (sIRB) review. Many institutions must now establish policies and processes for working with an external sIRB.
When conducting an investigator-initiated trial, oftentimes, an investigational new drug or investigational device exemption application is necessary. Learn more about IND and IDE reporting.